Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Bruckner-Tuderman L, Uitto J (2001) Progress in molecular dermatology. Acta Dermato Venereol (Stockh) 81: 161–162
Burgeson R, Christiano A (1997) The dermal-epidermal junction. Curr Opin Cell Biol 9: 651–658
Hertl M, Schuler G (2002) Klassifikation und Pathogenese bullöser Autoimmundermatosen. Hautarzt 53: 207–221
*Anhalt GJ, Kim S, Stanley JR (1990) Paraneoplastic pemphigus: an autoimmune mucocutaneous disease associated with neoplasia. N Engl J Med 323: 1729–1735
*Beutner EH, Jordon RE (1964) Demonstration of skin antibodies in sera of pemphigus vulgaris patients by indirect immunofluorescence staining. Proc Soc Exp Biol Med 117: 505–510
Chan LS, Vanderlugt CJ, Hashimoto T et al. (1998) Epitope spreading: lessons from autoimmune skin disease. J Invest Dermatol 110: 103–109
*Cazenave P (1844) Pemphigus chronique, general; forme rare de pemphigus foliace; mort; autopsie; alteration du foie. Ann Mal Peau Syph 1: 208–210
Diaz LA, Sampaio SAP, Rivitti EA et al. (1989) Endemic pemphigus foliaceus (Fogo Selvagem): II. Current and historic epidemiologic studies. J Invest Dermatol 92: 4–12
Fine J-D (1995) Management of acquired bullous skin diseases. N Engl J Med 333: 1475–1484
Hahn K, Kippes W, Amagai M et al. (2000) Klinik und Immunpathologie bei 48 Patienten mit Pemphigus. Hautarzt 51: 670–677
*Hallopeau H (1889) Sur une nouvelle forme de dermatite pustuleuse chronique en foyers a progression excentrique. In: Congrès International de Dermatologie et de Syphiligraphie tenu à Paris (le session). Masson, Paris, pp 344–362
*Huff JC, Golitz LE, Kunke KS (1985) Intraepidermal neutrophilic IgA dermatosis. N Engl J Med 313: 1643–1645
*Jablonska S, Chorzelski TP, Beutner EH et al. (1975) Herpetiform pemphigus, a variable pattern of pemphigus. Int J Dermatol 14: 353–359
Kunte C, Barbosa JM, Wolff H et al. (1997) Brasilianischer Pemphigus foliaceus (Fogo selvagem). Hautarzt 48: 228–233
*Lever WF (1953) Pemphigus. Medicine 32: 1–132
*Neumann I (1886) Über Pemphigus vegetans (frambosioides). Arch Derm Syph 18: 157–178
*Nikolski PV (1896) Materiali K. uchenigu o pemphigus Goliaceus [doctoral thesis]. Kiev
Plewig G, Jansen T, Jungblut RM et al. (1990) Castleman-Tumor, Lichen ruber und Pemphigus vulgaris: paraneoplastische Assoziation immunologischer Erkrankungen? Hautarzt 41: 552–670
Schmid E, Schmidt E, Bröcker EB et al. (2000) Pemphigus: Verlust des desmosomalen Zell-Zell-Kontaktes. Hautarzt 51: 309–318
*Senear FE, Usher B (1926) An unusual type of pemphigus. Arch Dermatol 13: 761–781
*Vieira JP (1940) Pemphigus foliaceus (fogo selvagem). Arch Dermatol 41: 858–863
Wallach D (1992) Intraepidermal IgA pustulosis. J Am Acad Dermatol 27: 993–1000
*Wallach D, Foldès C, Cottenot F (1982) Pustulose sous-cornée, acantholyse superficielle et IgA monoclonale. Ann Dermatol Venereol 109: 959–963
Zillikens D, Bröcker EB (1994) Paraneoplastischer Pemphigus. Hautarzt 45: 827–833
Axt M, Wever S, Baier G et al. (1995) Vernarbendes Pemphigoid — ein therapeutisches Problem. Hautarzt 46: 620–627
*Bean SF, Michel B, Furey N et al. (1976) Vesicular pemphigoid. Arch Dermatol 112: 1402–1404
Borradori L, Sonnenberg A (1999) Structure and function of hemidesmosomes: more than simple adhesion complexes. J Invest Dermatol 112: 411–418
*Brunsting LA, Perry HO (1957) Benign pemphigoid? A report of seven cases with chronic, scarring herpetiform plaques about the head and neck. Arch Dermatol 75: 489–501
Chan LS, Ahmed AR, Anhalt GJ et al. (2002) The first international consensus on mucous membrane pemphigoid: definition, diagnostic criteria, pathogenic factors, medical treatment and prognostic indicators. Arch Dermatol 138: 370–379
*Chorzelski TP, Jablonska S (1979) IgA linear dermatosis of childhood (chronic bullous disease of childhood). Br J Dermatol 101: 535–542
Domloge-Hultsch N, Gammon WR, Briggaman RA et al. (1992) Epiligrin, the major human keratinocyte integrin ligand, is a target in both an acquired autoimmune and an inherited subepidermal blistering skin disease. J Clin Invest 90: 1628–1633
Foster C (1986) Cicatricial pemphigoid. Trans Am Ophthalmol Soc 84: 527–663
Georgi M, Jainta S, Bröcker EB et al. (2001) Autoantigene subepidermal Blasen bildender Autoimmundermatosen. Hautarzt 52: 1079–1089
Hertl H, Schuler G (2002) Bullöse Autoimmundermatosen. Klassifikation. Hautarzt 53: 207–221
Jainta S, Schmidt E, Bröcker EB et al. (2001) Diagnostik und Therapie bullöser Autoimmunerkrankungen der Haut. Dtsch Ärztebl 98: A1320–1325
Jenkins RE, Hern S, Black MM (1999) Clinical features and management of 87 patients with pemphigoid gestationis. Clin Exp Dermatol 24: 255–259
Joly P, Roujeau JC, Benichon J et al. (2002) A comparison of oral and topical corticosteroids in patients with bullous pemphigoid. N Engl J Med 346: 321–327
*Jordon RE, Beutner EH, Witebsky E et al. (1967) Basement membrane antibodies in bullous pemphigoid. JAMA 200: 751–756
*Kaposi M (1892) Lichen ruber pemphigoides. Arch Dermatol Syph (Berlin) 24: 343–346
Khumalo N-P, Murrell D-F, Wojnarowska F et al. (2002) A systematic review of treatments for bullous pemphigoid. Arch Dermatol 138: 385–389
Kippes W, Schmidt E, Roth A et al. (1999) Immunpathologische Veränderungen bei 115 Patienten mit bullösem Pemphigoid. Hautarzt 50: 866–872
Korman NJ (1998) Bullous pemphigoid. The latest in diagnosis, prognosis and therapy. Arch Dermatol 134: 1137–1141
*Levine N, Freilich A, Barland P (1979) Localized pemphigoid simulating dyshidrosiform dermatitis. Arch Dermatol 115: 320–321
Messer G, Schirren H, Meurer M (1993) Herpes gestationis; immunologische und immungenetische Aspekte. Hautarzt 44: 761–766
*Milton J (1872) The pathology and treatment of diseases of the skin. Hardwicke, London, pp 205–209
Schmidt E, Bröcker E-B, Zillikens D (2000) Neue Aspekte zur Pathogenese des bullösen Pemphigoids. Hautarzt 51: 637–645
*Schnyder U (1969) Pemphigoide séborrhéique. Entité nosologique nouvelle? Bull Soc Fr Derm Syph 76: 320
Shimanovich I, Rose C, Hirako Y (2004) Anti-p200-Pemphigoid — eine neue blasenbildende Autoimmundermatose. JDDG 2: 7–14
Wever S, Burger M, Langfritz K et al. (1995) Herpes gestationis. Klinisches Spektrum und diagnostische Möglichkeiten. Hautarzt 46: 158–164
*Winkelmann RK, Su WPD (1979) Pemphigoid vegetans. Arch Dermatol 115: 446–448
Wojnarowska F, Marsden RA, Bhogal B et al. (1988) Chronic bullous disease of childhood, childhood cicatricial pemphigoid, and linear IgA disease of adults. J Am Acad Dermatol 19: 792–805
*Yung CW, Soltani K, Lorincz AL (1981) Pemphigoid nodularis. J Am Acad Dermatol 5: 54–60
Zillikens D (1999) Erworbene bullöse Dermatosen. In: Traupe H, Hamm H (Hrsg) Pädiatrische Dermatologie. Springer, Berlin, S 593–603
Zillikens D (1999) Acquired skin disease of hemidesmosomes. J Dermatol Sci 20: 134–154
Zillikens D, Kawahara Y, Ishiko A et al. (1996) A novel subepidermal blistering disease with autoantibodies against a 200-kDa antigen of the basement membrane zone. J Invest Dermatol 106: 465–470
Bruckner-Tuderman L, Höpfner B, Hammami-Hauasli N (1999) Biology of anchoring fibrils: lessons from dystrophic epidermolysis bullosa. Matrix Biol 18: 43–54
*Brunsting LA, Perry HO (1957) Benign pemphigoid? A report of seven cases with chronic, scarring herpetiform plaques about the head and neck. Arch Dermatol 75: 489–501
*Gammon WR, Briggaman RA (1993) Epidermolysis bullosa acquisita and bullous systemic lupus erythematosus. Diseases of autoimmunity to type VII collagen. Dermatol Clin 11: 535–547
Gammon WR, Briggaman RA, Woddley DT et al. (1984) Epidermolysis bullosa acquisita — a pemphigoid-like-disease. J Am Acad Dermatol 11: 820–832
Kirtschig G, Murrell D, Wojnarowska F et al. (2002) Interventions for mucous membrane pemphigoid/cicatricial pemphigoid and epidermolysis bullosa acquisita. Arch Dermatol 138: 380–384
*Roenigk HH, Ryan JG, Bergfield WF (1971) Epidermolysis bullosa acquisita. Arch Dermatol 103: 1–10
Schmidt E, Zillikens D (2000) Autoimmune and inherited subepidermal blistering diseases: advances in the clinical and the laboratory. Adv Dermatol 16: 113–157
Dieterich W, Laag E, Bruckner-Tuderman L et al. (1999) Antibodies to tissue transglutaminase as serologic markers in patients with dermatitis herpetiformis. J Invest Dermatol 113: 133–136
*Cottini GB (1955) Dermatite herpetiforme de Duhring symetrique et localise aux genome et aux condes. Ann Derm Syph 82: 285–286
*Duhring LA (1884) Dermatitis herpetiformis. JAMA 3: 225–229
Fry L (1995) Dermatitis herpetiformis. Baillieres Clin Gastroenterol 9: 371–393
Rose C, Dieterich W, Bröcker EB et al. (1999) Circulating autoantibodies to tissue transglutaminase differentiate patients with dermatitis herpetiformis from those with linear IgA disease. J Am Acad Dermatol 41: 957–961
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer Medizin Verlag Heidelberg
About this chapter
Cite this chapter
Zillikens, D. (2005). Bullöse Autoimmundermatosen. In: Braun-Falco, O., Plewig, G., Wolff, H.H., Burgdorf, W.H.C., Landthaler, M. (eds) Dermatologie und Venerologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-26624-0_43
Download citation
DOI: https://doi.org/10.1007/3-540-26624-0_43
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-40525-2
Online ISBN: 978-3-540-26624-2
eBook Packages: Medicine (German Language)